Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 10B BPA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118994222B reveals mild Grignard boronation for BNCT agents. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable routes.